- Home
- ETON vs DDI Comparison
ETON vs DDI Comparison
Compare ETON & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | DDI |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.9M | 433.6M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ETON | DDI |
|---|---|---|
| Price | $18.86 | $8.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $31.00 | $19.00 |
| AVG Volume (30 Days) | ★ 291.1K | 64.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,011,000.00 | N/A |
| Revenue This Year | $107.23 | $6.65 |
| Revenue Next Year | $29.72 | $2.64 |
| P/E Ratio | ★ N/A | $4.31 |
| Revenue Growth | ★ 23.29 | N/A |
| 52 Week Low | $11.09 | $8.09 |
| 52 Week High | $23.00 | $11.25 |
Technical Indicators
Market Signals| Indicator | ETON | DDI |
|---|---|---|
| Relative Strength Index (RSI) | 64.96 | 47.08 |
| Support Level | $16.04 | $8.64 |
| Resistance Level | $20.01 | $9.32 |
| Average True Range (ATR) | 1.08 | 0.32 |
| MACD | 0.10 | -0.02 |
| Stochastic Oscillator | 70.56 | 28.21 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.